Transaction · 0000947871-26-000980

Orbimed Advisors LLC

ORBIMED ADVISORS LLC, DIR, reported a transaction classified as unknown at Aspen Neuroscience, Inc. involving 616984.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code CDIR
ASPEAspen Neuroscience, Inc.
Trade date
Nov 02, 2026
Filing date
Nov 04, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded616k$0.00 per share
Holdings after0Indirect · See footnotes
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ASPE price since this filing

Daily closing prices, with the filing date and available return windows
ASPE · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
unknown
Code C
Identifier
0000947871-26-000980
Series A-2 Convertible Preferred Stock
Transaction date
Nov 02, 2026
Filed Nov 04, 2026, 11:43 PM · 2d delay
Shares
616,984 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Indirect · See footnotes

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction
Filing-only score

-12 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, as amended, each share of Series Seed-2 Convertible Preferred Stock, Series A-1 Convertible Preferred Stock, Series A-2 Conv…

  2. F2

    Reflects shares of the Issuer's Common Stock purchased in the Issuer's initial public offering.

  3. F3

    Securities held by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("OrbiMed GP") is the general partner of OPI VII. OrbiMed Advisors LLC ("OrbiMed Advisors") is the managi…

  4. F4

    This report on Form 4 is jointly filed by OrbiMed Advisors and OrbiMed GP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a)…

Original filing · 0000947871-26-000980
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ASPE